CD8A and neoplasm: Additionally, a new recombinant protein from Toxoplasma gondii, rGRA6Nt, has demonstrated the ability to limit tumor growth in murine colorectal cancer models while simultaneously tripling the density of CD8+ T cells within the tumors (94).